Abstract
Background
The Medicare Bundled Payments for Care Improvement (BPCI) program reimburses 90-day care episodes post-hospitalization. COPD is a leading cause of early readmissions making it a target for value-based payment reform.
Objective
Evaluate the financial impact of a COPD BPCI program.
Design, Participants, Interventions
A single-site retrospective observational study evaluated the impact of an evidence-based transitions of care program on episode costs and readmission rates, comparing patients hospitalized for COPD exacerbations who received versus those who did not receive the intervention.
Main Measures
Mean episode costs and readmissions.
Key Results
Between October 2015 and September 2018, 132 received and 161 did not receive the program, respectively. Mean episode costs were below target for six out of eleven quarters for the intervention group, as opposed to only one out of twelve quarters for the control group. Overall, there were non-significant mean savings of $2551 (95% CI: − $811 to $5795) in episode costs relative to target costs for the intervention group, though results varied by index admission diagnosis-related group (DRG); there were additional costs of $4184 per episode for the least-complicated cohort (DRG 192), but savings of $1897 and $1753 for the most complicated index admissions (DRGs 191 and 190, respectively). A significant mean decrease of 0.24 readmissions per episode was observed in 90-day readmission rates for intervention relative to control. Readmissions and hospital discharges to skilled nursing facilities were factors of higher costs (mean increases of $9098 and $17,095 per episode respectively).
Conclusions
Our COPD BPCI program had a non-significant cost-saving effect, although sample size limited study power. The differential impact of the intervention by DRG suggests that targeting interventions to more clinically complex patients could increase the financial impact of the program. Further evaluations are needed to determine if our BPCI program decreased care variation and improved quality of care.
Primary Source of Funding
This research was supported by NIH NIA grant #5T35AG029795-12.
Similar content being viewed by others
Data Availability
Since the data used in this manuscript are highly granular and contains potentially sensitive patient information, public sharing of the data would breach the University of Chicago’s IRB protocol requirements. Interested researchers may contact Valerie Press via email at vpress@medicine.bsd.uchicago.edu for data requests.
References
CDC - COPD Home Page - Chronic Obstructive Pulmonary Disease (COPD). Published January 29, 2019. Accessed July 9, 2019. https://www.cdc.gov/copd/index.html
Lindenauer PK, Pekow P, Gao S, Crawford AS, Gutierrez B, Benjamin EM. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2006;144(12):894–903. doi:https://doi.org/10.7326/0003-4819-144-12-200606200-00006
Shah T, Press VG, Huisingh-Scheetz M, White SR. COPD Readmissions: Addressing COPD in the Era of Value-based Health Care. CHEST. 2016;150(4):916–926. doi:https://doi.org/10.1016/j.chest.2016.05.002
Bhatt SP, Wells JM, Iyer AS, et al. Results of a Medicare Bundled Payments for Care Improvement Initiative for Chronic Obstructive Pulmonary Disease Readmissions. Ann Am Thorac Soc. 2017;14(5):643–648. doi:https://doi.org/10.1513/AnnalsATS.201610-775BC
CMS. Hospital Readmissions Reduction Program. Published January 16, 2019. Accessed April 16, 2019 https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html
CMS. Bundled Payments for Care Improvement (BPCI) Initiative: General Information | Center for Medicare & Medicaid Innovation. Accessed April 15, 2019 https://innovation.cms.gov/initiatives/bundled-payments/
Press VG, Au DH, Bourbeau J, et al. Reducing Chronic Obstructive Pulmonary Disease Hospital Readmissions. An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2019;16(2):161–170. doi:https://doi.org/10.1513/AnnalsATS.201811-755WS
CMS. BPCI Model 2: Retrospective Acute & Post Acute Care Episode. CMS Innovation Center. Accessed October 27, 2020 https://innovation.cms.gov/innovation-models/bpci-model-2
P Lindenauer, Au D, Chang W, LaBrin J, Mularski R, Press V. COPD Implementation Guide. Accessed December 19, 2020 https://www.hospitalmedicine.org/globalassets/clinical-topics/clinical-pdf/shm_chronic_obstructive_pulmonary_disease_program_guide.pdf
2021 GOLD Reports. Global Initiative for Chronic Obstructive Lung Disease - GOLD. Accessed March 14, 2021 https://goldcopd.org/2021-gold-reports/
Mueller SK, Sponsler KC, Kripalani S, Schnipper JL. Hospital-Based Medication Reconciliation Practices: A Systematic Review. Arch Intern Med. 2012;172(14):1057–1069. doi:https://doi.org/10.1001/archinternmed.2012.2246
Mueller SK, Kripalani S, Stein J, et al. A Toolkit to Disseminate Best Practices in Inpatient Medication Reconciliation: Multi-Center Medication Reconciliation Quality Improvement Study (MARQUIS). Jt Comm J Qual Patient Saf. 2013;39 (8) AP1-AP3 https://doi.org/10.1016/S1553-7250(13)39051-5
Paasche-Orlow MK, Riekert KA, Bilderback A, et al. Tailored Education May Reduce Health Literacy Disparities in Asthma Self-Management. Am J Respir Crit Care Med. 2005;172(8):980–986. doi:https://doi.org/10.1164/rccm.200409-1291OC
Press VG, Arora VM, Shah LM, et al. Misuse of respiratory inhalers in hospitalized patients with asthma or COPD. J Gen Intern Med. 2011;26(6):635-642. doi:https://doi.org/10.1007/s11606-010-1624-2
Press VG, Arora VM, Trela KC, et al. Effectiveness of Interventions to Teach Metered-Dose and Diskus Inhaler Techniques. A Randomized Trial. Ann Am Thorac Soc. 2016;13(6):816–824. doi:https://doi.org/10.1513/AnnalsATS.201509-603OC
Lash DB, Mack A, Jolliff J, Plunkett J, Joson JL. Meds-to-Beds: The impact of a bedside medication delivery program on 30-day readmissions. JACCP J Am Coll Clin Pharm. 2019;2(6):674–680. doi:https://doi.org/https://doi.org/10.1002/jac5.1108
Zillich AJ, Jaynes HA, Davis HB, et al. Evaluation of a “Meds-to-Beds” program on 30-day hospital readmissions. JACCP J Am Coll Clin Pharm. 2020;3(3):577–585. doi:https://doi.org/https://doi.org/10.1002/jac5.1183
Feemster LC, Au DH. Penalizing hospitals for chronic obstructive pulmonary disease readmissions. Am J Respir Crit Care Med. 2014;189(6):634–639. doi:https://doi.org/10.1164/rccm.201308-1541PP
Diagnosis Related Group (DRG). Accessed August 16, 2019. https://hmsa.com/portal/provider/zav_pel.fh.DIA.650.htm
CMS. BPCI Advanced. CMS Innovation Center. https://innovation.cms.gov/innovation-models/bpci-advanced
Desgagné A, Castilloux AM, Angers JF, Le Lorier J. The Use of the Bootstrap Statistical Method for the Pharmacoeconomic Cost Analysis of Skewed Data. PharmacoEconomics. 1998;13(5):487–497. doi:https://doi.org/10.2165/00019053-199813050-00002
Press VG. Is It Time to Move on from Identifying Risk Factors for 30-Day Chronic Obstructive Pulmonary Disease Readmission? A Call for Risk Prediction Tools. Ann Am Thorac Soc. 2018;15(7):801–803. doi:https://doi.org/10.1513/AnnalsATS.201804-246ED
Press VG, Myers LC, Feemster LC. Preventing COPD Readmissions Under the Hospital Readmissions Reduction Program How Far Have We Come? Chest. 2021 Mar;159(3): 996–1006. doi: https://doi.org/10.1016/j.chest.2020.10.008
Rinne ST, Press VG. Moving the Bar on Chronic Obstructive Pulmonary Disease Readmissions before and after the Hospital Readmission Reduction Program: Myth or Reality? Ann Am Thorac Soc. 2020;17(4):423–425. doi:https://doi.org/10.1513/AnnalsATS.202001-010ED
Press VG, Miller BJ. The Hospital Readmissions Reduction Program and COPD: More Answers, More Questions. J Hosp Med. 2020;15(4):252–253. doi:https://doi.org/10.12788/jhm.3362
van Walraven C, Bennett C, Jennings A, Austin PC, Forster AJ. Proportion of hospital readmissions deemed avoidable: a systematic review. CMAJ Can Med Assoc J J Assoc Medicale Can. 2011;183(7):E391–402. doi:https://doi.org/10.1503/cmaj.101860
Shah T, Churpek MM, Coca Perraillon M, Konetzka RT. Understanding Why Patients With COPD Get Readmitted: A Large National Study to Delineate the Medicare Population for the Readmissions Penalty Expansion. Chest. 2015;147(5):1219–1226. doi:https://doi.org/10.1378/chest.14-2181
Joynt KE, Jha AK. Thirty-Day Readmissions — Truth and Consequences. N Engl J Med. 2012;366(15):1366–1369. doi:https://doi.org/10.1056/NEJMp1201598
Joynt KE, Jha AK. Characteristics of Hospitals Receiving Penalties Under the Hospital Readmissions Reduction Program. JAMA. 2013;309(4):342–343. doi:https://doi.org/10.1001/jama.2012.94856
Hu J, Gonsahn MD, Nerenz DR. Socioeconomic status and readmissions: evidence from an urban teaching hospital. Health Aff Proj Hope. 2014;33(5):778–785. doi:https://doi.org/10.1377/hlthaff.2013.0816
Press VG, Konetzka RT, White SR. Insights about the economic impact of chronic obstructive pulmonary disease readmissions post implementation of the hospital readmission reduction program. Curr Opin Pulm Med. 2018;24(2):138–146. doi:https://doi.org/10.1097/MCP.0000000000000454
Joynt Maddox KE, Orav EJ, Zheng J, Epstein AM. Evaluation of Medicare’s Bundled Payments Initiative for Medical Conditions. N Engl J Med. 2018;379(3):260–269. doi:https://doi.org/10.1056/NEJMsa1801569
Rojas JC, Chokkara S, Zhu M, Lindenauer PK, Press VG. Care Quality for Patients with Chronic Obstructive Pulmonary Disease in the Readmission Penalty Era. Am J Respir Crit Care Med. 2023 Jan 1;207(1):29–37. doi: https://doi.org/10.1164/rccm.202203-0496OC.
Aboumatar H, Naqibuddin M, Chung S, et al. Effect of a Hospital-Initiated Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Patients Hospitalized With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial. JAMA. 2019;322(14):1371–1380. doi:https://doi.org/10.1001/jama.2019.11982
Acknowledgements
We thank the COPD Program advanced practice nurses. We also thank the Center for Transformative Care for their support of our BPCI program and for data assistance. Finally, we thank Mary Akel for her administrative assistance.
Funding
AW was supported in part by the NIH NIA grant #5T35AG029795-12. The funder played no role in the collection, design, or reporting of data for this work. These data were collected independently from any funding source.
Author information
Authors and Affiliations
Contributions
AW and VGP conceptualized this study, assisted with data collection and analyses, and interpreted the data, as well as drafted and revised the manuscript. TK, SC, RK, and SRW helped design of the study, interpreted the data, and critically revised the manuscript. WW assisted in data cleaning and data analyses, assisted with data interpretation, and critically revised the manuscript. AG contributed to data interpretation as well as critical revision of the manuscript. All authors reviewed and approved the final manuscript. They agree to be accountable for all aspects of the work.
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Prior Presentations.
We previously presented these findings at our institution, the University of Chicago, as a poster at the 2019 Janet Rowley Department of Medicine Research Day, the Sixth Annual Research Symposium and Poster Session by the Center for Chronic Disease Research and Policy, and the 2018 UCM Quality Fair. We have also presented the work as a poster for the 2020 American Thoracic Society Annual Meeting and as an oral presentation at the 2020 Midwest Society of General Internal Medicine Annual Conference.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Waltman, A., Konetzka, R.T., Chia, S. et al. Effectiveness of a Bundled Payments for Care Improvement Program for Chronic Obstructive Pulmonary Disease. J GEN INTERN MED 38, 2662–2670 (2023). https://doi.org/10.1007/s11606-023-08249-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11606-023-08249-6